Further, treatment with the DNA methyltransferase inhibitor Aza inhibited proliferation and growth of all tested NSCLC cell lines while concomitantly significantly augmenting the expression of all four members of the TBX2 subfamily. This evidence concerns the gene TBX2 and non-small cell lung carcinoma.